INTRODUCTION
Several observations are compatible with the possibility that cyclic 3',5'-adenosine monophosphate (AMP) may mediate hormonal effects as a "second messenger" in the leukocyte. (a) Glucagon activates human leukocyte phosphorylase in vitro, and may do so by the same mechanism as in the liver (1) . (b) Methylxanthines potentiate epiReceived for publication 19 October 1970 and in revised form 7 December 1970. nephrine's inhibitory effect on the release of granulocyte histamine triggered by antigen-reagin complexes in vitro (2) . Such potentiation can usually be demonstrated in tissues in which an effect of epinephrine is mediated by cyclic 3',5'-AMP. (c) Epinephrine and prostaglandin E1 (PGEi) stimulate accumulation of cyclic 3',5'-AMP in human leukocytes (3) . (d) Cyclic AMP and theophylline inhibit release of lysosomal B-glucuronidase by phagocytic leukocytes (4) .
We have found that adenyl cyclase and phosphodiesterase are present in the human leukocyte, and that intact leukocytes can synthesize radioactive cyclic 3',5'-resuspended in 20 ml of 0.32 M sucrose and again centrifuged at 150 g for 10 min, after which the button contained [15] [16] [17] [18] [19] [20] leukocytes to one platelet (see Results). Contaminating erythrocytes were then removed by hypotonic lysis (5) , and the final leukocyte button was resuspended in 0.32 M sucrose (2-3 X 10' leukocytes per ml). The cell suspension was subjected to sonication for 30 sec in a Biosonik sonicator (Brownwill Scientific, Rochester, N. Y.) at a setting of 40, which was sufficient to break up 95% of the leukocytes. This sonicate served as the source of enzyme in both the adenyl cyclase and phosphodiesterase assays.
Isolation of leukocytes for studies other than adenyl cyclase and phosphodiesterase. After sedimentation with dextran as described above, the leukocyte-rich supernatant was washed twice by centrifugation (150 g for 10 min at 200C) in Hanks' balanced salt solution (BSS) containing 20% fetal calf serum and 2 U/ml of sodium heparin (Riker Laboratories, Northridge, Calif.). For studies of respiration and glucose oxidation, contaminating red cells were removed by hypotonic lysis (5) . For measurement of candidacidal activity and of conversion of adenine-'H to cyclic 3',5'-AMP-'H, the cells were resuspended in Hanks' BSS containing 25% normal AB human serum. For the other studies McCoy's or Spinner-modified minimal essential medium was substituted for Hanks' BSS, and cells were present at 1-2 X 107/ml. Isolation of platelets. In two experiments the supernatant fluid after centrifugation (150 g) of leukocyte-rich plasma was used as a source of platelets for the adenyl cyclase assay. This supernatant fluid was centrifuged at 1200 g for 10 min at 4°C, and the platelet button was washed with sucrose and exposed to hypotonic lysis of red cells, followed by sonication, exactly as described above.
Isolation of lymphocytes. After sedimentation of heparinized blood with dextran, lymphocytes were separated from other leukocytes on a glass-wool column (6) . The resulting lymphocyte preparations, 97-100% pure, were resuspended in ice-cold 0.32 M sucrose and subjected to repeated centrifugation, hypotonic lysis of erythrocytes, and sonication under the same conditions described for leukocytes and platelets.
Assay of adenyl cyclase. Adenyl cyclase was measured as described by Krishna, Weiss, and Brodie (7) . The incubation mixture contained, in a final volume of 0. (8, 9 ) and brain slices (10) was adapted to human leukocytes as follows. To a 20 ml suspension of leukocytes (1 X 10'/ml) in Hanks' BSS containing 25%o human AB serum, 10 1OCi of adenine-'H (6 Ci/mmole) was added, and the mixture was incubated for 40 min (unless otherwise noted) at 370C. At the end of this preincubation, 2-ml aliquots of the cell suspension were added to 25-ml Erlenmeyer flasks containing appropriate amounts of the drugs to be studied, and the incubation was continued at 370C for another 10 min. The reaction was terminated by centrifugation at OC and 800 g for 1 min. An aliquot of the supernatant fluid was removed for measurement of radioactivity, the cell button was resuspended in 0.7 ml of water containing 0.5 mg nonradioactive cyclic 3',5'-AMP, and the tube was immersed in boiling water for 3 min. After centrifugation the supernatant fluid was subjected to the same Dowex 50-Hf chromatography and Ba(OH)2-ZnSOi precipitation described above. Recovery of cyclic 3',5'-AMP was measured by optical density, as in the adenyl cyclase assay. Radioactivity of 1 ml of the Ba(OH)2-ZnSO4 supernatant was determined in a liquid scintillation spectrometer. Results were expressed as per cent of adenine-'H radioactivity recovered in cyclic 3',5'-AMP per 10' leukocytes per 10 min. Confirmation that measured radioactivity was cyclic 3',5'-AMP. "C and 'H radioactivity in the third column fraction after Ba(OH)2-ZnSO4 precipitation was tested for authenticity by comparison with authentic cyclic 3',5'-AMP in four ways.
(a) Samples were placed on a Dowex 1-Cl-column and eluted with 0.01 N Ha as described by Krishna et al. (7) . Recovery from the column of either the 'H or the IC radioactivity and the authentic cyclic 3',5'-AMP was quantitative (95-100%).
( In both systems the 14C and authentic cyclic 3',5'-AMP were easily separated from adenosine, ATP, ADP, and 5-AMP.
(c) The specific activity of a mixture of "unknown" 'C and authentic nonradioactive cyclic 3',5'-AMP remained constant through three successive recrystallizations (Table I , column A).
(d) Further evidence that this 'C radioactivity was authentic cyclic 3',5'-AMP was obtained by incubating a mixture of the "unknown" 'C and authentic eH nucleotide with a purified preparation of phosphodiesterase.
In the absence of enzyme the 'C was eluted from Dowex 50-Ho in the same fractions as authentic cyclic 3',5'-AMP-'H ( Fig. 2 A, top) . The phosphodiesterase, however, converted about 50% of both the 'C and the 'H to a product which appears in a later peak (Fig' 2 A,  bottom) . The second peak coincides with that of authentic 5-AMP. Treatment of the column fractions with Ba(OH)2 and ZnSO4 caused both the SC and 'H in the second peak to precipitate quantitatively (like 5-AMP [5] ), while radioactivity in the first peak remained in the supernatant. The phosphodiesterase reaction was not carried to completion because the supply of purified en- In order to assess the contribution of platelet adenyl cyclase to the total enzyme activity measured in our usual preparations, the enzyme was measured in both platelets and leukocytes of two patients. The ratio of leukocytes to platelets was measured by phase microscopy of the "leukocyte" suspension just before sonication. The results (Table II) confirmed earlier reports (14) that adenyl cyclase is present in blood platelets, but platelets could not have contributed more than 1 % of the total enzyme activity measured in our leukocyte preparations.
Similarly, the relative contribution of lymphocytes to the adenyl cyclase measured in our mixed population of leukocytes was determined by measuring adenyl cyclase in purified preparations of lymphocytes from two patients. On a per-cell basis lymphocytes contained less than 20% of the adenyl cyclase activity present in the preparation of mixed leukocytes (Table II) , although enzyme activity per milligram cell protein (not shown) was unchanged. Since lymphocytes accounted for 26-30% of the total cells present in such preparations, they contributed less than 5% of the total adenyl cyclase activity in our mixed leukocyte suspensions.
The stimulatory effects of three prostaglandins on leukocyte adenyl cyclase activity was examined. A doseresponse curve for prostaglandin E1, the most powerful stimulator of the three, is shown in Fig. 3 . Activation of cyclase was maximal at 10' M PGE1, and half-maximal at about 10 mole/liter. The effects on leukocyte adenyl cyclase of two other prostaglandins, PGE and PGEla are shown in Table III . Leukocytes of four subjects varied in basal as well as drug-stimulated enzyme activity, when values were expressed on the basis of leukocyte protein. When values were normalized, with enzyme activity in the presence of NaF being taken as 100% for each individual subject, the relative effects of the prostaglandins and NaF were quite consistent from subject to subject. NaF was the most powerful stimulator. At 10' mole/liter, PGEi was a more active stimulator than PGE2, and PGF1a was inactive.
Degradation of cyclic 3',5'-AMP by sonicated leukocytes. Disappearance of cyclic 3',5'-AMP was linear with time (0-40 min) and increasing amounts of sonicate protein (0-7 mg). Like adenyl cyclase, leukocyte degradative activity varied but averaged 800 ±280 (SD) pmoles/mg protein per min in four subjects. Theophylline (1 X 10-mole/liter) produced 44 ±10% (SD) inhibition of nucleotide degradation in leukocytes from these four subjects (P < 0.01 by paired t test). In one additional experiment, caffeine (1 X 10' mole/liter) produced similar inhibition of degradation (68%).
Incorporation of adenine-'H into cyclic 3',5'-AMP-'H.
Intact leukocytes removed 80% of adenine-'H from the extracellular medium in 40 min (Fig. 4 A) . (c) The "unknown" 'H was successively recrystallized to constant specific activity (Table I, 
column B). (d)
The purified phosphodiesterase converted both the 'H and authentic "C-labeled nucleotide to 5'-AMP (Fig.  2 B) . After the standard 40 min preincubation, PGEL in the presence of theophylline (1 X 10' mole/liter) produced a dose-dependent increase in intracellular cyclic 3',5'-AMP-'H (Fig. 3) . As with adenyl cyclase, half-maximal effect was produced by about 10' M PGE1. If theophylline inhibited degradation of cyclic 3',5'-AMP in intact cells as it does in broken cell preparations, it might be expected that 'H-labeled nucleotide would accumulate in the presence of theophylline alone, but it did not (Table IV). Lack of accumulation could be due to a relatively low basal rate of synthesis of the nucleotide, incomplete inhibition of degradation, or leakage of cyclic 3',5'-AMP from the cell (9). PGE1 (1 X 10-' mole/liter) produces a marked increase in accumulation of cyclic 3',5'-AMP-'H; the increase is potentiated by theophylline (Table IV) , an effect which is consistent with stimulation of nucleotide synthesis combined with inhibition of nucleotide degradation.
The three prostaglandins tested showed the same order of potency in stimulating intracellular accumulation of the cyclic nucleotide as on adenyl cyclase. At 10' mole/ liter, PGE1 was a better stimulator than PGE2, and PGF16 had relatively little effect (Table IV) (Table IV) .
In three experiments (not shown) purified lymphocytes also incorporated radioactive adenine into cyclic 3',5'-AMP and responded to PGEi and theophylline in the same way. On a per-cell basis, this incorporation was slightly less than that of the mixed leukocyte preparations. This suggests that in the mixed leukocyte preparations the contribution by lymphocytes to the measured accumulation of cyclic nucleotide was of the same order I Difference from control significant at P < 0.01, by paired I test. I Difference from control significant at P < 0.05, by paired t test.
of magnitude as their percentage in the differential count of leukocytes in the individual subjects (25-30%).
Granulocyte function Phagocytosis. Preincubation of neutrophils for 30
min with dibutyryl cyclic 3',5'-AMP (3 X 10' mole/ liter), PGEi (1 X 10' mole/liter), and theophylline (3 X 10' mole/liter) produced a slight but consistent inhibitory effect on ingestion of C. albicans (P < 0.01), whether measured at a single time point (15 min) (Table  V) or over 15 min, using radioactively labeled yeasts (Fig. 5) . Reduction of phagocytosis was achieved without observable impairment of leukocyte viability (trypan blue exclusion). Metabolic studies. Neutrophils (1.5 X 107/ml) were preincubated with or without drug for 15 min before the addition of Candida albicans in an enclosed chamber containing an oxygen electrode. Dibutyryl cyclic 3',5'-AMP, PGEi, and theophylline produced no change in the slow rate of basal oxygen consumption or in the magnitude of the respiratory burst associated with phagocytosis (Table VI) .
The production of 14CO2 from glucose-l-'4C by leukocytes was measured during the 30 min after addition of Candida. Leukocytes were preincubated with saline or drug for 30 min before the addition of particles. PGE1 had a modest inhibitory effect on glucose-l-C oxidation by phagocytic leukocytes, whereas theophylline and dibutyryl cyclic 3',5'-AMP had no effect (Table VI) .
Electron microscopy after phagocytosis. Thin sec-tions were prepared from pellets of phagocytic leukocytes incubated in the presence or absence of dibutyryl cyclic 3',5'-AMP (3 X 10' mole/liter), theophylline (3 X 10-' mole/liter), or PGE5 (1 X 10 mole/liter) and examined by electron microscopy. When sections were coded and examined as unknowns, we could detect no difference between control and drug-treated samples in regard to extent of degranulation or the discharge of granule contents into the phagocytic vacuoles. Granulocyte candidacidal activity. Theophylline and dibutyryl cyclic 3',5'-AMP greatly diminished the ability of normal leukocytes to kill ingested Candida albicans. PGE, was less potent but produced statistically significant inhibition (Table VII) . Since stock solutions of PGE1 (3 X 10-' mole/liter) were made with absolute ethanol, incubation tubes containing 1 X 10' M PGE, also contained 0.33% ethanol (v/v); however, this concentration of ethanol did not affect candidacidal activitv (Table VII) .
Candida cells preincubated with the various drugs and then washed with Hanks' BSS before their addition to leukocytes were killed to the same extent as organisms incubated in Hanks' BSS alone, indicating that the drugs acted to impair leukocyte function rather than to increase the resistance of the ingested fungi to intraleukocytic events. The inhibition of candidacidal activity could not be attributed to alterations in phagocytosis, because ingestion occurred to completion by 15 min after addition of Candida to cells in a ratio of 1: 1, even in the presence of drugs.
The possibility that theophylline might potentiate the effect of PGE1 was examined by using a combination of the two drugs at concentrations which individually produced small and not statistically significant changes in leukocyte candidacidal activity. In eight experiments the average inhibitory effect of the two drugs combined was greater than the sum of their individual inhibitory effects, but this difference was not statistically significant (Table VII) . The relative activities of the prostaglandins in stimulating leukocyte adenyl cyclase is the same as that described in platelets (Table VIII) , although NaF produced a much greater relative stimulation in leukocytes than in platelets (14) . PGE,, the most potent prostaglandin tested, produced small but detectable stimulation of enzyme activity at about 1 X 10' mole/liter (Fig.  3) , several orders of magnitude higher than the concentrations of prostaglandins described in human plasma. Accordingly, PGE1 may prove useful as a pharmacologic tool for investigation of the metabolism and function of cyclic 3',5'-AMP, but a "physiologic" effect of the compound on adenyl cyclase in leukocytes cannot be proposed on the basis of these experiments. The same qualification holds true for platelets.
Sonicates of human leukocytes are capable of degrading cyclic 3',5'-AMP. Since the simple assay procedure we employed measured disappearance of the nucleotide rather than the appearance of product, it is not possible to be sure that degradation of the nucleotide was entirely due to a specific phosphodiesterase. However, the degradative activity was partially inhibited by theophylline and caffeine, an effect which has been described for phosphodiesterases from other tissues (15) . (a) Theophylline (1 X 10' mole/liter) is a better inhibitor of candidacidal activity than is PGE1, but the converse is true when accumulation of cyclic 3',5'-AMP-'H derived from adenine-'H is examined. It is difficult to know how much weight to place on this discrepancy, which might be resolved by measurement of intracellular cyclic 3',5'-AMP concentrations.
(b) Although the inhibitory effect of theophylline on leukocyte candidacidal activity was additive to that of PGE1 (Table VII) , a synergistic effect of the two drugs was not demonstrated (as it should be if the drugs act only by inhibition of phosphodiesterase and stimulation of adenyl cyclase, respectively). The failure to demon-strate synergism could be due to incorrect choice of concentration of either drug, as pointed out by Sutherland, Robison, and Butcher (15) . Practical considerations would make more detailed examination of many doses of the drugs individually and in combination extremely difficult.
(c) PGEI's effects on adenyl cyclase and candidacidal activity may be independent of one another. Additional compounds which stimulate adenyl cyclase must be studied. Our laboratory is presently investigating the effect of catecholamines on adenyl cyclase and leukocyte function, since it has been suggested that isoproterenol and epinephrine inhibit histamine release from leukocytes by stimulating adenyl cyclase (2) . When a specific inhibitor of adenyl cyclase activation (e.g. a betaadrenergic blocking agent vs. isoproterenol) becomes available, more critical experiments can be designed.
(d) Although the dibutyryl derivative of cyclic 3',5'-AMP inhibits granulocyte function at the relatively high concentrations required to mimic the effects of endogenous nucleotide in other tissues (15) , it could produce its effect by mechanisms not related to cyclic 3',5'-AMP. Nonspecific or inconsistent effects of dibutyryl cyclic 3',5'-AMP have been described in heart (16).
If cyclic 3',5'-AMP does prove to mediate any or all of the pharmacologic effects of theophylline and the prostaglandins on leukocyte function, the question of the possible physiologic role of the endogenous nucleotide in leukocytes may still remain open. Exploration of this question will involve further investigation of other possible influences on adenyl cyclase or phosphodiesterase activity (e.g. immune complexes, catecholamines, and phagocytosis) and functions of the leukocyte in addition to candidacidal activity (e.g. motility, release of possible mediators of inflammation).
